| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8546d028451f0334fbee4155e029e692 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
2014-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc635f56c77d3a96662dd228b44ca056 |
| publicationDate |
2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015058151-A2 |
| titleOfInvention |
Methods of using spect/ct analysis for staging cancer |
| abstract |
A method of evaluating a subject suspected of harboring a prostrate tumor includes administering to the subject an effective amount of a gamma-emitting transition metal complex conjugated to a targeting moiety that selectively binds to prostate-specific membrane antigen (PSMA), including PSMA expressed on the surface of a prostate tumor; subjecting the subject to a nuclear medicine tomographic imaging technique to obtain one or more images of at least a portion of prostate tissue that comprises tumor lesions; assessing a level of uptake of said gamma-emitting transition metal complex conjugated to a targeting moiety by said at least a portion of prostate tissue compared to a level of uptake by control tissue; and determining if a ratio of the level of uptake by said at least a portion of prostate tissue compared the level of uptake by control tissue is at or above a predetermined threshold. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10740880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10664999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11508063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017096407-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019527740-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-263886-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-263886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071501-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11721428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017046839-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11257584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019180153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017348111-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11657508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11424035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11676359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10176408-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017220488-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11321844-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10755810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11386988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019537714-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109312004-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11113812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11544407-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11120312-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11087459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11087460-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11094058-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607179-B2 |
| priorityDate |
2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |